Molecular features evaluation of metastatic foci as the basis for metastatic breast cancer treatment personalization. Is there a place of CDK4/6-inhibitors in late-line therapy after chemotherapeutic regimens?

The problem of metastatic breast cancer treatment is linked with clonal selection both in the process of tumor evolution and under the  influence of  previous treatment. The  analysis of  metastatic niche microenvironment and the  molecular genetic features become essential for treatment individuali...

Cur síos iomlán

Sonraí bibleagrafaíochta

Príomhchruthaitheoirí:	A. I. Stukan, A. Y. Goryainova, E. V. Lymar, S. V. Sharov, V. V. Antipova
Formáid:	Artigo
Teanga:	Russo
Foilsithe / Cruthaithe:	Remedium Group LLC 2021-12-01
Sraith:	Медицинский совет
Ábhair:	receptor status metastatic focus discordance premetastatic niche breast cancer combined hormonal therapy cdk4/6 inhibitors
Rochtain ar líne:	https://www.med-sovet.pro/jour/article/view/6580
Clibeanna:	Cuir clib leis Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!